Especially, FEZF1-AS1 and UCA1 are detected in serum and exosomes recovered from serum of ovarian cancer patients, respectively, which suggested their potential as liquid biopsy markers for ovarian cancer. This evidence concerns the gene FEZF1 and ovarian cancer.